Unverified50% confidenceOpinionExact time
Medical fine-tuning does not reduce overall risk; rather, it changes the composition of risk.
1
Sources
50%
Confidence
Long-term
Relevance
10/20/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedIn cancer treatment, the next line of therapy usually changes the drug mechanism rather than reloading an analog of the drug that just failed, because a split highly correlated with one already made brings almost no new information (cross-resistance).64% similarUnverifiedIn medical settings, patient disease severity is a typical confounder, as it determines both whether medication is administered and directly affects the outcome.64% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1074888API
curl https://kongchang.com/api/v1/knowledge/claims/1074888MCP
get_claim(id=1074888)